Optimizing PrEP Uptake and Adherence Among Male Sex Workers
- Conditions
- Prevention
- Interventions
- Behavioral: Stage 1 Strength Based Case Management (SBCM) ConditionBehavioral: Stage 2 PrEPare for Work Intervention Condition
- Registration Number
- NCT05736614
- Lead Sponsor
- Brown University
- Brief Summary
"PrEPare for Work" is a randomized controlled trial (RCT) whose goal is to test the efficacy of a behavioral intervention (Short Title: PrEPare for Work) in improving PrEP uptake, adherence, and persistence among male sex workers (MSW)
- Detailed Description
A theory-based, manualized intervention -called "PrEPare for Work"-includes two separate but complementary interventions that address MSW-specific behavioral, economic, interpersonal \& structural-level barriers to accessing and adhering to PrEP: 1) peer-led, strengths-based case management (SBCM) for PrEP linkage and uptake; and 2) a technology and counseling intervention to optimize PrEP adherence (once they have access to PrEP). This research will test the PrEPare for Work intervention in a fully-powered RCT to assess efficacy and cost-effectiveness.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 500
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Stage 1 Strength Based Case Management (SBCM) Condition Stage 1 Strength Based Case Management (SBCM) Condition Intervention participants will receive a trained SBCM to motivate, support, and assist in linkage to PrEP prescribers to help facilitate obtaining PrEP medication to initiate treatment. Stage 2 PrEPare for Work Intervention Condition Stage 2 PrEPare for Work Intervention Condition Intervention participants will receive 1-on-1 adherence counseling and personalized daily text messaging reminders to increase PrEP adherence. Intervention participants will undergo three adherence intervention sessions (once per week for 3 weeks) with interventionist.
- Primary Outcome Measures
Name Time Method Stage one: PrEP initiation 2-month post Stage 1 randomization Stage one: PrEP initiation will be measured via verification of prescription filled within two months post-randomization, associated medical records from a PrEP prescriber, and self-report.
Stage two: PrEP adherence 12-month post Stage 2 randomization Stage two: PrEP adherence will be measured via tenofovir concentration in hair. Self-reported adherence will supplement biological monitoring data at 4-month intervals.
- Secondary Outcome Measures
Name Time Method PrEP persistence 12-month post Stage 2 randomization PrEP persistence will be measured via medical records and self-report. We will assess PrEP persistence using medical and pharmacy records to confirm provider follow-up visits and prescription refill maintenance. As per Coy et al., PrEP persistence will be defined as having โฅ16 days of PrEP medication filled per 30-day period, for at least three-quarters of the months since initiation to study completion (\~9 months).
Trial Locations
- Locations (5)
UCLA Fielding School of Public Health
๐บ๐ธLos Angeles, California, United States
The Miriam Hospital
๐บ๐ธProvidence, Rhode Island, United States
Open Door Health
๐บ๐ธProvidence, Rhode Island, United States
Project Weber/RENEW
๐บ๐ธProvidence, Rhode Island, United States
Brown University School of Public Health
๐บ๐ธProvidence, Rhode Island, United States